Integra LifeSciences appoints Renee Lo as independent director

INTEGRA LIFESCIENCES HOLDINGS CORP

Renee Lo appointed to board effective July 18, 2022, filling an existing vacancy.
Lo is a general manager at Microsoft leading data and AI business in Asia; previously at Amazon and SAP.
She will receive pro-rated annual board retainer and director equity grant under company policy.
Board determined Lo is independent under Nasdaq and SEC rules; no standing committees assigned yet.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Renee Wonlai Lo

director

IART · INTEGRA LIFESCIENCES HOLDINGS CORP

Effective: 2022-07-18
Filed: July 19, 2022, 7:59 PM ET

On July 18, 2022, the Board of Directors ("Board") of Integra LifeSciences Holdings Corporation (the "Company") appointed Renee Wonlai Lo as a director of the Company, effective immediately, to fill an existing vacancy on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Renee Wonlai Lo was appointed as director at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action: appointed
Role: director

Exact text from the filing

On July 18, 2022, the Board of Directors ("Board") of Integra LifeSciences Holdings Corporation (the "Company") appointed Renee Wonlai Lo as a director of the Company, effective immediately, to fill an existing vacancy on the Board.

View on SEC.gov

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0000917520-22-000029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.